You are here

Docket Number 3585

Received: 
Friday, December 17, 2021
Commodity: 
Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same
Investigation Number: 
Pending Institution
Filed By: 
Mareesa A. Frederick
Firm/Organization: 
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Behalf Of: 
AbbVie Inc., AbbVie Biotechnology Ltd, and AbbVie Operations Singapore Pte. Ltd.
Confidential: 
Yes
Country: 
None
Description: 
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, in the matter of certain adalimumab, processes for manufacturing or relating to same, and products containing same. The proposed respondents are Alvotech hf., Iceland; Alvotech Germany GmbH, Germany; Alvotech Swiss AG, Switzerland; Alvotech USA Inc., Arlington, VA; Teva Pharmaceutical Industries Ltd., Israel; Teva Pharmaceuticals USA Inc., North Wales, PA; and Ivers-Lee AG, Switzerland.
Petition/Complaint Status: 
Pending Institution